Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin is a highly conserved protein that forms heterodimers (α- and β-tubulin) assembling into dynamic microtubules, key structural elements of the cytoskeleton[3][4][6]. The tubulin polymerisation process is essential for cell division, intracellular transport, and maintenance of cell architecture. This process is the primary target of several therapeutic agents, especially antimitotic anticancer drugs, which disrupt microtubule dynamics to arrest cell cycle progression and induce cell death. Inhibition or aberrant regulation of tubulin polymerisation is also involved in the pathophysiology of neurodegenerative and infectious diseases[3][4][6].
Inhibition of tubulin polymerisation (e.g., colchicine, vincristine) Stabilisation of microtubules (e.g., paclitaxel) Disruption of microtubule dynamics causing mitotic arrest and apoptosis
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin polymerisation process.